IRIS Accounts Production v25.1.4.42 04319719 Board of Directors 1.12.23 30.11.24 30.11.24 Medium entities the importation and distribution of batteries. true false true true false false false true false These accounts have been prepared in accordance with the provisions applicable to companies subject to the medium-sized companies regime. Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh043197192023-11-30043197192024-11-30043197192023-12-012024-11-30043197192022-11-30043197192022-12-012023-11-30043197192023-11-3004319719ns15:EnglandWales2023-12-012024-11-3004319719ns14:PoundSterling2023-12-012024-11-3004319719ns10:Director12023-12-012024-11-3004319719ns10:PrivateLimitedCompanyLtd2023-12-012024-11-3004319719ns10:MediumEntities2023-12-012024-11-3004319719ns10:Audited2023-12-012024-11-3004319719ns10:Medium-sizedCompaniesRegimeForDirectorsReport2023-12-012024-11-3004319719ns10:Medium-sizedCompaniesRegimeForAccounts2023-12-012024-11-3004319719ns10:FullAccounts2023-12-012024-11-300431971912023-12-012024-11-3004319719ns10:OrdinaryShareClass12023-12-012024-11-3004319719ns10:Director22023-12-012024-11-3004319719ns10:RegisteredOffice2023-12-012024-11-3004319719ns5:CurrentFinancialInstruments2024-11-3004319719ns5:CurrentFinancialInstruments2023-11-3004319719ns5:ShareCapital2024-11-3004319719ns5:ShareCapital2023-11-3004319719ns5:RetainedEarningsAccumulatedLosses2024-11-3004319719ns5:RetainedEarningsAccumulatedLosses2023-11-3004319719ns5:ShareCapital2022-11-3004319719ns5:RetainedEarningsAccumulatedLosses2022-11-3004319719ns5:RetainedEarningsAccumulatedLosses2022-12-012023-11-3004319719ns5:RetainedEarningsAccumulatedLosses2023-12-012024-11-3004319719ns5:IntangibleAssetsOtherThanGoodwill2023-12-012024-11-3004319719ns5:PatentsTrademarksLicencesConcessionsSimilar2023-12-012024-11-3004319719ns5:LongLeaseholdAssetsns5:LandBuildings2023-12-012024-11-3004319719ns5:PlantMachinery2023-12-012024-11-3004319719ns5:FurnitureFittings2023-12-012024-11-3004319719ns15:UnitedKingdom2023-12-012024-11-3004319719ns15:UnitedKingdom2022-12-012023-11-3004319719ns15:Europe2023-12-012024-11-3004319719ns15:Europe2022-12-012023-11-3004319719ns5:TotalGeographicSegmentsIncludingAnyUnallocatedAmount2023-12-012024-11-3004319719ns5:TotalGeographicSegmentsIncludingAnyUnallocatedAmount2022-12-012023-11-3004319719ns5:OwnedAssets2023-12-012024-11-3004319719ns5:OwnedAssets2022-12-012023-11-3004319719ns5:PatentsTrademarksLicencesConcessionsSimilar2022-12-012023-11-3004319719112023-12-012024-11-3004319719112022-12-012023-11-300431971912023-12-012024-11-300431971912022-12-012023-11-3004319719ns10:OrdinaryShareClass12022-12-012023-11-3004319719ns5:PatentsTrademarksLicencesConcessionsSimilar2023-11-3004319719ns5:PatentsTrademarksLicencesConcessionsSimilar2024-11-3004319719ns5:PatentsTrademarksLicencesConcessionsSimilar2023-11-3004319719ns5:LongLeaseholdAssetsns5:LandBuildings2023-11-3004319719ns5:PlantMachinery2023-11-3004319719ns5:FurnitureFittings2023-11-3004319719ns5:LongLeaseholdAssetsns5:LandBuildings2024-11-3004319719ns5:PlantMachinery2024-11-3004319719ns5:FurnitureFittings2024-11-3004319719ns5:LongLeaseholdAssetsns5:LandBuildings2023-11-3004319719ns5:PlantMachinery2023-11-3004319719ns5:FurnitureFittings2023-11-3004319719ns5:WithinOneYearns5:CurrentFinancialInstruments2024-11-3004319719ns5:WithinOneYearns5:CurrentFinancialInstruments2023-11-3004319719ns5:WithinOneYear2024-11-3004319719ns5:WithinOneYear2023-11-3004319719ns5:BetweenOneFiveYears2024-11-3004319719ns5:BetweenOneFiveYears2023-11-3004319719ns5:MoreThanFiveYears2024-11-3004319719ns5:MoreThanFiveYears2023-11-3004319719ns5:AllPeriods2024-11-3004319719ns5:AllPeriods2023-11-3004319719ns5:DeferredTaxation2023-11-3004319719ns5:DeferredTaxation2024-11-3004319719ns10:OrdinaryShareClass12024-11-3004319719ns5:RetainedEarningsAccumulatedLosses2023-11-30
REGISTERED NUMBER: 04319719 (England and Wales)















Strategic Report, Report of the Directors and

Financial Statements for the Year Ended 30 November 2024

for

Ultracell (UK) Limited

Ultracell (UK) Limited (Registered number: 04319719)






Contents of the Financial Statements
for the Year Ended 30 November 2024




Page

Company Information 1

Strategic Report 2

Report of the Directors 3

Report of the Independent Auditors 5

Income Statement 9

Other Comprehensive Income 10

Balance Sheet 11

Statement of Changes in Equity 12

Cash Flow Statement 13

Notes to the Cash Flow Statement 14

Notes to the Financial Statements 15


Ultracell (UK) Limited

Company Information
for the Year Ended 30 November 2024







DIRECTORS: D J Murray
Miss M C McGuinness





REGISTERED OFFICE: 7 Vesty Business Park
Vesty Road
Bootle
Liverpool
Merseyside
L30 1NY





REGISTERED NUMBER: 04319719 (England and Wales)





AUDITORS: Xeinadin Audit Limited
116 Duke Street
Liverpool
Merseyside
L1 5JW

Ultracell (UK) Limited (Registered number: 04319719)

Strategic Report
for the Year Ended 30 November 2024

The directors present their strategic report for the year ended 30 November 2024.

The company's business consists of the the importation and distribution of batteries.

REVIEW OF BUSINESS
We have continued to perform well during the year in spite of the recent economic slowdown.
Overall turnover has decreased by just over £740k (4.6%), cost of sales has decreased by £397k (3.1%) leaving the company with a reduced but good gross profit of 18.2%.

The company's reserves at the year end increased by £141,232 and that was after paying dividends of £446,200, leaving the reserves at a healthy £1,002,675. The cash balances of nearly £2.5m are sufficient to manage foreign currency fluctuations, cost price increases and any decline in the sector.

PRINCIPAL RISKS AND UNCERTAINTIES
The company is exposed to fluctuations in demand that could arise due to changes in the economic climate. We manage this by ensuring that we have sufficient reserves to fund any period of decline.

The company is exposed to foreign exchange risk as some products are purchased in US Dollars and sold in Sterling. We manage this risk by holding funds in US Dollars and Euros and by forward buying currency.

FUTURE DEVELOPMENTS
The company has invested in the manufacture of a new range of lithium batteries that are more environmentally friendly.

ON BEHALF OF THE BOARD:





D J Murray - Director


27 November 2025

Ultracell (UK) Limited (Registered number: 04319719)

Report of the Directors
for the Year Ended 30 November 2024

The directors present their report with the financial statements of the company for the year ended 30 November 2024.

DIVIDENDS
An interim dividend of £223100 per share was paid on 30 April 2024. The directors recommend that no final dividend be paid.

The total distribution of dividends for the year ended 30 November 2024 will be £ 446,200 .

FUTURE DEVELOPMENTS
Details of future developments are included within the Review of Business in the Strategic Report.

DIRECTORS
The directors shown below have held office during the whole of the period from 1 December 2023 to the date of this report.

D J Murray
Miss M C McGuinness

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law), including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'. Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

-select suitable accounting policies and then apply them consistently;
-make judgements and accounting estimates that are reasonable and prudent;
-prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps that he or she ought to have taken as a director in order to make himself or herself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

Ultracell (UK) Limited (Registered number: 04319719)

Report of the Directors
for the Year Ended 30 November 2024


AUDITORS
The auditors, Xeinadin Audit Limited, will be proposed for re-appointment at the forthcoming Annual General Meeting.

ON BEHALF OF THE BOARD:




D J Murray - Director


27 November 2025

Report of the Independent Auditors to the Members of
Ultracell (UK) Limited

Opinion
We have audited the financial statements of Ultracell (UK) Limited (the 'company') for the year ended 30 November 2024 which comprise the Income Statement, Other Comprehensive Income, Balance Sheet, Statement of Changes in Equity, Cash Flow Statement and Notes to the Cash Flow Statement, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the company's affairs as at 30 November 2024 and of its profit for the year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information
The directors are responsible for the other information. The other information comprises the information in the Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

Report of the Independent Auditors to the Members of
Ultracell (UK) Limited


Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
- the financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities set out on page three, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Report of the Independent Auditors to the Members of
Ultracell (UK) Limited


Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

Identifying and Assessing Potential Risks Related to Irregularities
Enquiring of management, including obtaining and reviewing supporting documentation concerning the company's policies and procedures relating to:
Identifying, evaluating and complying with laws and regulations and whether they were aware of any instances of non-compliance
detecting and responding to the risks of fraud and whether they have knowledge of any actual, suspected or alleged fraud
the internal controls established to mitigate risks related to fraud or non-compliance with laws and regulations
discussing among the engagement team including relevant internal specialists, including tax, valuations, pensions and IT regarding how and where fraud might occur in the financial statements and any potential indicators of fraud
obtaining an understanding of the legal and regulatory framework that the company operates in, focusing on those laws and regulations that had a direct effect on the financial statements or that had a fundamental effect on the operations of the company. The key laws and regulations we considered in this context included the Companies Act 2006, Pension legislation, Tax legislation, and Health and Safety requirements.

Audit Response to Risks Identified
In addition to the above, our procedures to respond to risks identified included the following:
reviewing the Financial Statement disclosures and testing to supporting documentation to assess compliance with relevant laws and regulations discussed above;
enquiring of management concerning actual and potential litigation and claims;
performing analytical procedures to identify any unusual or unexpected relationships that may indicate risks of material misstatement due to fraud; and
in addressing the risk of fraud through management override of controls, testing the appropriateness of journal entries and other adjustments; assessing whether the judgements made in making accounting estimates are indicative of a potential bias; and evaluating the business rationale of any significant transactions that are unusual or outside the normal course of business.

We also communicated relevant identified laws and regulations and potential fraud risks to all engagement team and remained alert to any indications of fraud or non-compliance with laws and regulations throughout the audit.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

Report of the Independent Auditors to the Members of
Ultracell (UK) Limited


Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Philip Harrison (Senior Statutory Auditor)
for and on behalf of Xeinadin Audit Limited
116 Duke Street
Liverpool
Merseyside
L1 5JW

27 November 2025

Ultracell (UK) Limited (Registered number: 04319719)

Income Statement
for the Year Ended 30 November 2024

30.11.24 30.11.23
Notes £    £   

TURNOVER 3 15,147,550 15,887,620

Cost of sales 12,202,976 12,788,137
GROSS PROFIT 2,944,574 3,099,483

Administrative expenses 1,927,075 1,781,184
OPERATING PROFIT 5 1,017,499 1,318,299

Interest receivable and similar income 7,930 24,699
1,025,429 1,342,998

Interest payable and similar expenses 6 10,218 10,233
PROFIT BEFORE TAXATION 1,015,211 1,332,765

Tax on profit 7 427,779 238,227
PROFIT FOR THE FINANCIAL YEAR 587,432 1,094,538

Ultracell (UK) Limited (Registered number: 04319719)

Other Comprehensive Income
for the Year Ended 30 November 2024

30.11.24 30.11.23
Notes £    £   

PROFIT FOR THE YEAR 587,432 1,094,538


OTHER COMPREHENSIVE INCOME - -
TOTAL COMPREHENSIVE INCOME
FOR THE YEAR

587,432

1,094,538

Ultracell (UK) Limited (Registered number: 04319719)

Balance Sheet
30 November 2024

30.11.24 30.11.23
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 9 61,985 44,588
Tangible assets 10 2,432,468 1,933,348
2,494,453 1,977,936

CURRENT ASSETS
Stocks 11 1,442,861 840,494
Debtors 12 612,193 1,500,684
Cash at bank and in hand 2,466,779 973,768
4,521,833 3,314,946
CREDITORS
Amounts falling due within one year 13 5,565,217 4,169,621
NET CURRENT LIABILITIES (1,043,384 ) (854,675 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,451,069

1,123,261

PROVISIONS FOR LIABILITIES 15 448,394 261,818
NET ASSETS 1,002,675 861,443

CAPITAL AND RESERVES
Called up share capital 16 2 2
Retained earnings 17 1,002,673 861,441
SHAREHOLDERS' FUNDS 1,002,675 861,443

The financial statements were approved by the Board of Directors and authorised for issue on 27 November 2025 and were signed on its behalf by:





D J Murray - Director


Ultracell (UK) Limited (Registered number: 04319719)

Statement of Changes in Equity
for the Year Ended 30 November 2024

Called up
share Retained Total
capital earnings equity
£    £    £   
Balance at 1 December 2022 2 1,020,903 1,020,905

Changes in equity
Dividends - (1,254,000 ) (1,254,000 )
Total comprehensive income - 1,094,538 1,094,538
Balance at 30 November 2023 2 861,441 861,443

Changes in equity
Dividends - (446,200 ) (446,200 )
Total comprehensive income - 587,432 587,432
Balance at 30 November 2024 2 1,002,673 1,002,675

Ultracell (UK) Limited (Registered number: 04319719)

Cash Flow Statement
for the Year Ended 30 November 2024

30.11.24 30.11.23
Notes £    £   
Cash flows from operating activities
Cash generated from operations 1 1,782,680 812,385
Interest paid (10,218 ) (10,233 )
Tax paid 10,013 (113,470 )
Net cash from operating activities 1,782,475 688,682

Cash flows from investing activities
Purchase of intangible fixed assets (26,070 ) (5,389 )
Purchase of tangible fixed assets (900,641 ) (389,293 )
Interest received 7,930 24,699
Net cash from investing activities (918,781 ) (369,983 )

Cash flows from financing activities
Amount introduced by directors 2,034,570 1,254,000
Amount withdrawn by directors (959,053 ) (1,054,549 )
Equity dividends paid (446,200 ) (1,254,000 )
Net cash from financing activities 629,317 (1,054,549 )

Increase/(decrease) in cash and cash equivalents 1,493,011 (735,850 )
Cash and cash equivalents at beginning of
year

2

973,768

1,709,618

Cash and cash equivalents at end of year 2 2,466,779 973,768

Ultracell (UK) Limited (Registered number: 04319719)

Notes to the Cash Flow Statement
for the Year Ended 30 November 2024

1. RECONCILIATION OF PROFIT BEFORE TAXATION TO CASH GENERATED FROM
OPERATIONS

30.11.24 30.11.23
£    £   
Profit before taxation 1,015,211 1,332,765
Depreciation charges 217,189 224,167
Loss on disposal of fixed assets 193,004 -
Finance costs 10,218 10,233
Finance income (7,930 ) (24,699 )
1,427,692 1,542,466
Increase in stocks (602,367 ) (268,946 )
(Increase)/decrease in trade and other debtors (167,623 ) 141,614
Increase/(decrease) in trade and other creditors 1,124,978 (602,749 )
Cash generated from operations 1,782,680 812,385

2. CASH AND CASH EQUIVALENTS

The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect of these Balance Sheet amounts:

Year ended 30 November 2024
30.11.24 1.12.23
£    £   
Cash and cash equivalents 2,466,779 973,768
Year ended 30 November 2023
30.11.23 1.12.22
£    £   
Cash and cash equivalents 973,768 1,709,618


3. ANALYSIS OF CHANGES IN NET FUNDS

At 1.12.23 Cash flow At 30.11.24
£    £    £   
Net cash
Cash at bank and in hand 973,768 1,493,011 2,466,779
973,768 1,493,011 2,466,779
Total 973,768 1,493,011 2,466,779

Ultracell (UK) Limited (Registered number: 04319719)

Notes to the Financial Statements
for the Year Ended 30 November 2024

1. STATUTORY INFORMATION

Ultracell (UK) Limited is a private company, limited by shares, registered in England and Wales. The company's registered number is 04319719 and the registered office is 7 Vesty Business Park, Liverpool, Merseyside L30 1NY.

The presentation currency of the financial statements is the Pound Sterling (£).

The principal activities of the company are the importation and distribution of batteries.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The directors consider that the going concern assumption is appropriate despite the net current liability position as they believe they will be able to meet company obligations as they become due.

Significant judgements and estimates
In the application of the company's accounting policies, management is required to make judgements, estimates and assumptions about carrying values of assets and liabilities that are not readily available from other sources. The estimates and underlying assumptions are based on experience and other factors considered to be relevant. Actual results may differ from these estimates.
The key judgements and sources of estimation uncertainty that have a significant effect on the amounts recognised in the financial statements are described below:

Estimated useful lives and residual values of fixed assets
As described in the accounting policies, depreciation and amortisation of tangible and intangible fixed assets has been based on estimated useful lives and residual values deemed appropriate by the directors. Estimated useful lives and residual values are reviewed annually and revised if necessary. The carrying amount of fixed assets at the end of the reporting period was £2,432,468 after a depreciation charge of £208,517.

Turnover
Turnover is measured at the fair value of the consideration received or receivable on the importation and distribution of batteries, excluding discounts, rebates, value added tax and other sales taxes. Income is recognised when goods are despatched.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised evenly over their estimated useful life of ten years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Long leasehold - 15% on cost, 10% on cost and 5% on cost
Plant and machinery - 10% on cost and 5% on cost
Fixtures and fittings - 20% on cost, 15% on cost, 10% on cost and 5% on cost

Fixed assets are recognised at cost, less depreciation and impairment where necessary.

Ultracell (UK) Limited (Registered number: 04319719)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2024

2. ACCOUNTING POLICIES - continued

Stocks
Inventories are stated at the lower of cost and estimated selling price less costs to sell. Inventories are recognised as an expense in the period in which the related revenue is recognised. Cost is determined on the first-in, first-out (FIFO) method. Cost includes the purchase price, including taxes and duties and transport and handling directly attributable to bringing the inventory to its present location and condition. At the end of each reporting period inventories are assessed for impairment. If an item of inventory is impaired, the identified inventory is reduced to its selling price less costs to complete and sell and an impairment charge is recognised in the profit and loss account. Where a reversal of the impairment is required the impairment charge is reversed, up to the original impairment loss, and is recognised as a credit in the profit and loss account.

Financial instruments
Financial assets that are measured at amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in profit and loss.

Trade debtors and other debtors are recognised initially at fair value and subsequently measured at amortised cost less provision for impairment. A provision for impairment in trade debtors is established when there is evidence that the company will not be able to collect all amounts due.

Trade creditors represent outstanding invoices due to suppliers for purchases made, trade creditors are paid within the terms given by the supplier.

Director's loans and intercompany loans (being repayable on demand), are measured at the undiscounted amount of the cash or other consideration expected to be paid or received.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Ultracell (UK) Limited (Registered number: 04319719)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2024

2. ACCOUNTING POLICIES - continued

Cash and cash equivalents
Cash at bank and in hand is represented by amounts deposited at the company bank accounts, cash is available immediately on request.

3. TURNOVER

The turnover and profit before taxation are attributable to the one principal activity of the company.

An analysis of turnover by geographical market is given below:

30.11.24 30.11.23
£    £   
United Kingdom 133,990 149,248
Europe 5,238,523 6,397,088
Non EU 9,775,037 9,341,284
15,147,550 15,887,620

4. EMPLOYEES AND DIRECTORS
30.11.24 30.11.23
£    £   
Wages and salaries 642,730 778,785
Other pension costs 8,692 10,149
651,422 788,934

The average number of employees during the year was as follows:
30.11.24 30.11.23

Staff 24 28

The company operates a defined contribution pension scheme that all employees in that company are entitled to join. The cost for the year amounted to £8,692 (2023 - £10,149). Included in other creditors is £1,502 (2023 - £1,843) relating to pension contributions unpaid at the year end.

30.11.24 30.11.23
£    £   
Directors' remuneration 23,368 23,662

5. OPERATING PROFIT

The operating profit is stated after charging:

30.11.24 30.11.23
£    £   
Depreciation - owned assets 208,517 216,433
Loss on disposal of fixed assets 193,004 -
Patents and licences amortisation 8,673 7,732
Auditors' remuneration 7,056 6,000
Auditors' remuneration for non audit work 5,660 21,620
Rent 212,861 238,079

Ultracell (UK) Limited (Registered number: 04319719)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2024

6. INTEREST PAYABLE AND SIMILAR EXPENSES
30.11.24 30.11.23
£    £   
Other interest 10,218 10,233

7. TAXATION

Analysis of the tax charge
The tax charge on the profit for the year was as follows:
30.11.24 30.11.23
£    £   
Current tax:
UK corporation tax 269,930 302,136
Amendment to prior year (28,727 ) (85,979 )
Total current tax 241,203 216,157

Deferred tax 186,576 22,070
Tax on profit 427,779 238,227

Reconciliation of total tax charge included in profit and loss
The tax assessed for the year is higher than the standard rate of corporation tax in the UK. The difference is explained below:

30.11.24 30.11.23
£    £   
Profit before tax 1,015,211 1,332,765
Profit multiplied by the standard rate of corporation tax in the UK of 25%
(2023 - 23.011%)

253,803

306,683

Effects of:
Expenses not deductible for tax purposes 53,077 3,396
Depreciation in excess of capital allowances 149,626 26,887
Utilisation of tax losses - (12,760 )
Adjustments to tax charge in respect of previous periods (28,727 ) (85,979 )
Total tax charge 427,779 238,227

8. DIVIDENDS
30.11.24 30.11.23
£    £   
Interim 446,200 1,254,000

Ultracell (UK) Limited (Registered number: 04319719)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2024

9. INTANGIBLE FIXED ASSETS
Patents
and
licences
£   
COST
At 1 December 2023 85,760
Additions 26,070
At 30 November 2024 111,830
AMORTISATION
At 1 December 2023 41,172
Amortisation for year 8,673
At 30 November 2024 49,845
NET BOOK VALUE
At 30 November 2024 61,985
At 30 November 2023 44,588

10. TANGIBLE FIXED ASSETS
Fixtures
Long Plant and and
leasehold machinery fittings Totals
£    £    £    £   
COST
At 1 December 2023 1,021,254 188,815 2,264,008 3,474,077
Additions 207,498 4,998 688,145 900,641
Disposals (352,184 ) - (372,611 ) (724,795 )
At 30 November 2024 876,568 193,813 2,579,542 3,649,923
DEPRECIATION
At 1 December 2023 522,134 100,334 918,261 1,540,729
Charge for year 49,903 15,991 142,623 208,517
Eliminated on disposal (288,247 ) - (243,544 ) (531,791 )
At 30 November 2024 283,790 116,325 817,340 1,217,455
NET BOOK VALUE
At 30 November 2024 592,778 77,488 1,762,202 2,432,468
At 30 November 2023 499,120 88,481 1,345,747 1,933,348

11. STOCKS
30.11.24 30.11.23
£    £   
Stocks 1,442,861 840,494

Ultracell (UK) Limited (Registered number: 04319719)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2024

12. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.11.24 30.11.23
£    £   
Trade debtors 535,365 369,427
Directors' current accounts - 1,056,114
VAT 28,162 24,956
Prepayments 48,666 50,187
612,193 1,500,684

13. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.11.24 30.11.23
£    £   
Trade creditors 4,395,085 3,392,021
Tax 553,352 302,136
Social security and other taxes 10,838 15,480
Other creditors 499,147 415,405
Directors' current accounts 19,404 -
Accrued expenses 87,391 44,579
5,565,217 4,169,621

14. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
30.11.24 30.11.23
£    £   
Within one year 254,693 229,144
Between one and five years 1,280,000 958,217
In more than five years - 122,194
1,534,693 1,309,555

Property leases are over 10 years, rent reviews are carried out every 5 years.

15. PROVISIONS FOR LIABILITIES
30.11.24 30.11.23
£    £   
Deferred tax 448,394 261,818

Deferred
tax
£   
Balance at 1 December 2023 261,818
Accelerated capital allowances 186,576
Balance at 30 November 2024 448,394

Ultracell (UK) Limited (Registered number: 04319719)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2024

16. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 30.11.24 30.11.23
value: £    £   
2 Ordinary £1 2 2

All shares issued are non-redeemable and rank equally in terms of:-
(a) voting rights- one vote for each share
(b) rights to participate in all dividend distributions for that class of share; and
(c) rights to participate in any capital distribution on winding up

17. RESERVES
Retained
earnings
£   

At 1 December 2023 861,441
Profit for the year 587,432
Dividends (446,200 )
At 30 November 2024 1,002,673

18. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The company paid rent in the year totalling £212,861 (2023 £238,079) to the directors, D Murray and M McGuinness.

Both D Murray and M McGuinness, directors, operate current accounts with the company to which transactions of a private nature are charged. As at 30th November 2024, D Murray was owed £3,679 (2023 - Debtor £689,509) and M McGuinness was owed £15,725 (2023 - Debtor £366,605) to the company, which is included in other creditors. The loans are repayable on demand and interest has been charged at HMRC rates.

19. ULTIMATE CONTROLLING PARTY

The company is controlled by D Murray and M McGuinness by virtue of their shareholding